Reduced dose of tocilizumab for the maintenance of remission in patients with rheumatoid arthritis: a clinical experience

被引：0
|
作者：
Oscar Epis
Cinzia Casu
Laura Belloli
Emanuela Schito
Davide Filippini
Marina Muscarà
Eleonora Bruschi
机构：
[1] Niguarda Ca’ Granda Hospital,Rheumatology Unit
来源：
Rheumatology International | 2015年 / 35卷
关键词：
Rheumatoid Arthritis; Rheumatoid Arthritis Patient; Clinical Remission; Tocilizumab; Disease Remission;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1569 / 1570
页数：1
相关论文
共 50 条
  • [41] Therapeutic Drug Monitoring on Rheumatoid Arthritis Patients with Reduced Doses of Intravenous Tocilizumab
    Ruiz-Esquide, Virginia
    Bastida, Carla
    Pascal, Mariona
    Yague, Jordi
    Soy, Dolors
    Sanmarti, Raimon
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [42] Clinical efficacy of tocilizumab in patients with active rheumatoid arthritis in real clinical practice
    Yasuhiko Hirabayashi
    Tomonori Ishii
    Hideo Harigae
    Rheumatology International, 2010, 30 : 1041 - 1048
  • [43] Clinical efficacy of tocilizumab in patients with active rheumatoid arthritis in real clinical practice
    Hirabayashi, Yasuhiko
    Ishii, Tomonori
    Harigae, Hideo
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (08) : 1041 - 1048
  • [44] THERAPEUTIC DRUG MONITORING ON RHEUMATOID ARTHRITIS PATIENTS WITH REDUCED DOSES OF INTRAVENOUS TOCILIZUMAB
    Ruiz-Esquide, V.
    Bastida, C.
    Pascal, M.
    Yague, J.
    Soy, D.
    Sanmarti, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 840 - 840
  • [45] Predicting Remission Among Patients With Rheumatoid Arthritis Starting Tocilizumab Monotherapy: Model Derivation and Remission Score Development
    Collins, Jamie E.
    Johansson, Fredrik D.
    Gale, Sara
    Kim, Seoyoung
    Shrestha, Swastina
    Sontag, David
    Stratton, Jacklyn
    Huong Trinh
    Xu, Chang
    Losina, Elena
    Solomon, Daniel H.
    ACR OPEN RHEUMATOLOGY, 2020, 2 (02) : 65 - 73
  • [46] Not Only 5 but Also 6 Weeks Intervals of Tocilizumab Infusion Induce Clinical Remission in Patients with Active Rheumatoid Arthritis
    Uda, Hiroshi
    Shigematsu, Koji
    Ishizaki, Yoshitaka
    Saiki, Osamu
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [47] ASSESSING MAINTENANCE OF REMISSION WITH REDUCED DOSE ETANERCEPT PLUS METHOTREXATE, METHOTREXATE ALONE, OR PLACEBO IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS WHO ACHIEVED REMISSION WITH ETANERCEPT AND METHOTREXTATE: THE PRIZE STUDY
    Emery, P.
    Hammoudeh, M.
    FitzGerald, O.
    Combe, B.
    Martin Mola, E.
    Bukowski, J.
    Pedersen, R.
    Williams, T.
    Gaylord, S.
    Vlahos, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 399 - 399
  • [48] Clinical remission in rheumatoid arthritis and psoriatic arthritis
    Lubrano, E.
    Mesina, F.
    Caporali, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (05) : 900 - 910
  • [49] IMPLEMENTATION OF A REDUCED RITUXIMAB MAINTENANCE REGIMEN FOR PATIENTS WITH RHEUMATOID ARTHRITIS
    McGrath, Catherine M.
    Kumari, Ruchika
    Carruthers, David
    RHEUMATOLOGY, 2018, 57
  • [50] Dose Reduction Of Tocilizumab In Rheumatoid Arthritis Patients With Low Disease Activity Is Feasible
    van Herwaarden, Noortje
    Herfkens-Hol, Susan
    van der Maas, Aatke
    van Den Bemt, Bart J. F.
    van Vollenhoven, Ronald F.
    Bijlsma, Johannes W. J.
    den Broeder, Alfons A.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S992 - S992
12345